FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

A phase 3 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 180 participants.

Also called NCT07181135

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07181135
  • EU CT 2025-523075-32-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Enrolling by invitation (from the registry)

Technical summary

Registry record NCT07181135. Randomized; double masking; primary purpose treatment. Start 2026-03-13 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
Acronym
FINE-START
Intervention (Drug)
Finerenone (BAY 94-8862)
Intervention (Drug)
Placebo
Lead sponsor
University Medical Center Groningen (class: other)

Record details

Record id
cardio:ct-nct07181135
Content hash
17eeaeacbb9af12bd6394d50129a3a3aea15d162b5b99e54e9afc1fee7348540